A murine model of zygomycosis by Cunninghamella bertholletiae

Mycopathologia

Volumn 144, Issue 3, 1998, Pages 141-146

  Honda, Akira ^a   Kamei, Katsuhiko ^a   Unno, Hiromichi ^a   Hiroshima, Kenzo ^a   Kuriyama, Takayuki ^a   Miyaji, Makoto ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Cunninghamella bertholletiae; Murine model; Zygomycosis

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; CORTISONE; CORTISONE ACETATE; CYCLOPHOSPHAMIDE; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT;

ANIMAL; ARTICLE; BLOOD VESSEL; CUNNINGHAMELLA; DISEASE MODEL; HUMAN; INSTITUTE FOR CANCER RESEARCH MOUSE; LUNG; LUNG MYCOSIS; MALE; MICROBIOLOGY; MOUSE; MUCORMYCOSIS; PATHOGENICITY; PATHOLOGY; VASCULARIZATION;

AMPHOTERICIN B; ANIMALS; ANTIBIOTICS, ANTIFUNGAL; BLOOD VESSELS; CORTISONE; CUNNINGHAMELLA; CYCLOPHOSPHAMIDE; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG; LUNG DISEASES, FUNGAL; MALE; MICE; MICE, INBRED ICR; MUCORMYCOSIS;

ANIMALIA; CUNNINGHAMELLA BERTHOLLETIAE; FUNGI; MURINAE;

EID: 0032324347     PISSN: 0301486X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007095831301     Document Type: Article

References (22)

1. Walsh TJ, Karp J, Pizzo PA. Fungal infections of the respiratory tract. In: Kibbler CC, Mackenzie DWR, Odds FC, eds. Principles and practice of medical mycology. Chichester: John Wiley and Sons 1996: 235-268.
2. Cohen-Abbo A, Bozeman PM, Patrick CC. Cunninghamella infections: Review and report of two cases of Cunninghamella pneumonia in immunocompromised children. Clin Infect Dis 1993; 17: 173-177.
3. Weitzman I, Crist MY. Studies with clinical isolates of Cunninghamella. II. Physiological and morphological studies. Mycologia 1980; 72: 661-669.
4. Kwong-Chung KJ, Bennett JE. Mucormycosis. In: Medical mycology. Philadelphia: Lea & Febiger 1992: 524-559.
5. Kontoyianis DP, Vartivarian S, Anaissie EJ, Samonis G, Bodey GP, Rinaldi M. Infections due to Cunninghamella bertholletiae in patients with cancer: Report of three cases and review. Clin Infect Dis 1994; 18: 925-928.
6. Shishihara T, Kamei K, Edo H, Kuriyama T, Nishimura K, Miyaji M. A case of lung mucormycosis with erythrodcrma caused by Cunninghamella bertholletiae. Resp Res 1997; 16: 967-971.
7. Maloisel F, Dufour P, Waller J, Herbrecht R, Marcellin L, Koenig H, Liu KL, Weber J-C, Bergerat J-P, Oberling F. Cunninghamella bertholletiae: An uncommon agent of opportunistic fungal infection. Nouv Rev Fr Hematol 1991; 33: 311-315.
8. Hutter RVP. Phycomycetous infection (mucormycosis) in cancer patients: A complication of therapy. Cancer 1959; 12: 330-350.
9. Ng TTC, Campbell CK, Rothera M, Houghton JB, Hughes D, Denning DW. Successful treatment of sinusitis caused by Cunninghamella bertholletiae. Clin Infect Dis 1994; 19: 313-316.
10. Goldani L, Sugar AM. Treatment of murine pulmonary mucormycosis with SCH 42427, a broad-spectrum triazole antifungal drug. J Antimicrob Chemother 1994; 33: 369-372.
11. Waldorf AR, Levitz SM, Diamond RD. In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus. J Infect Dis 1984; 150: 752-760.
12. Waldorf AR, Ruderman N, Diamond RD. Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus. J Clin Invest 1984; 74: 150-160.
13. Anand VK, Alemar G, Griswold Jr JA. Intracranial complications of mucormycosis: An experimental model and clinical review. Laryngoscope 1992; 102: 656-662.
14. Abe F, Inaba H, Katoh T, Hotchi M. Effects of iron and desferriexamine on Rhizopus infection. Mycopathol 1990; 110: 87-91.
15. Boelaert JR, van Cutsem J, de Locht M, Schneider Y, Crichton RR. Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect. Kidney International 1994; 45: 667-671.
16. Jensen HE, Aalbæk B, Hau J. Induction of systemic zygomycosis in pregnant mice by Absidia corymbifera. Laboratory Animal Science 1995; 45: 254-257.
17. Sodhi MPS, Khanna RNS, Chand P. Experimental Absidia corymbifera infection in rabbits: Clinicopathological studies. Mycopathol 1996; 134: 7-11.
18. Waldorf AR, Halde C, Vedros NA. Murine model of pulmonary mucormycosis in cortisone-treated mice. Sabouraudia 1982; 20: 217-224.
19. Walsh TJ, Rinaldi MR, Pizzo PA. Zygomycosis of the respiratory tract. In: Sarosi GA, Davies SF, eds. Fungal diseases of the lung. 2nd ed. New York: Raven Press 1993: 149-170.
20. Diamond RD, Krzesicki R, Epstein B, Jao W. Damage to hyphal forms of fungi by human leukocytes in vitro. A possible host defense mechanism in aspergillosis and mucormycosis. Amer J Pathol 1978; 91: 313-328.
21. Schell WA, Johnson MG, McGinnis MR, Weitzman I, Crist MY. Zygomycosis caused by Cunninghamella bertholletiae. Arch Pathol Lab Med 1982; 106: 287-291.
22. Sugar AM. Agents of mucormycosis and related species. In: Mandell GL, Douglas Jr RG, Bennett JE, eds. Principles and practice of infectious diseases. 3rd ed. New York: Churchill Livingstone 1990: 1962-1972.